Market Research Life Sciences Market Research Pharmaceuticals Market Research Vaccines Market Research

Influenza Vaccines Global Market Opportunities And Strategies To 2033

Best Price Guarantee Length Publisher Published Date SKU
from $7,500 291 Pages The Business Research Company January, 2025 BRC19511472
Best Price Guarantee
Price from $7,500
Length 291 Pages
Publisher The Business Research Company
Published Date January, 2025
SKU BRC19511472

Influenza Vaccines Global Market Opportunities And Strategies To 2033

Including: 1) By Vaccine: Inactivated; Live Attenuated; Recombinant2) By Valency: Quadrivalent; Trivalent3) By Route Of Administration: Injection; Nasal Spray4) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply5) By Age Group: Pediatric; AdultCovering: Sanofi SA; Seqirus (CSL Limited); GlaxoSmithKline Plc; Daiichi Sankyo Co Ltd; Pfizer Inc


Influenza Vaccines Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global influenza vaccines market as it emerges from the COVID-19 shut down.

Reasons to Purchase:
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for influenza vaccines? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The influenza vaccines market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider influenza vaccines market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by vaccine type, by valency, by route of administration, by age group and by distribution channel.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the influenza vaccines market.
  • Global Market Size And Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
    • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
    • Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by vaccine type, by valency, by route of administration, by age group and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
    • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
    • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
    • Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
    • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
    • Competitive Dashboard- Briefs on competitive dashboard of major players.
    • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
    • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
    • Conclusions And Recommendations- This section includes recommendations for influenza vaccines providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
    • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
    Markets Covered:

    1) By Vaccine: Inactivated; Live Attenuated; Recombinant

    2) By Valency: Quadrivalent; Trivalent

    3) By Route Of Administration: Injection; Nasal Spray

    4) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply; Other Distribution Channels

    5) By Age Group: Pediatric; Adult

    Companies Mentioned: Sanofi SA; Seqirus (CSL Limited); GlaxoSmithKline Plc; Daiichi Sankyo Co Ltd; Pfizer Inc

    Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.

    Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

    Time-series: Five years historic and ten years forecast.

    Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; influenza vaccines indicators comparison.

    Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

    Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


    1 Executive Summary
    1.1 Influenza Vaccines – Market Attractiveness And Macro economic Landscape
    2 Table Of Contents
    3 List Of Tables
    4 List Of Figures
    5 Report Structure
    6 Market Characteristics
    6.1 General Market Definition
    6.2 Summary
    6.3 Influenza Vaccines Market Definition And Segmentations
    6.4 Market Segmentation By Vaccine Type
    6.4.1 Inactivated
    6.4.2 Live Attenuated
    6.4.3 Recombinant
    6.5 Market Segmentation By Valency
    6.5.1 Quadrivalent
    6.5.2 Trivalent
    6.6 Market Segmentation By Route Of Administration
    6.6.1 Injection
    6.6.2 Nasal Spray
    6.7 Market Segmentation By Age Group
    6.7.1 Pediatric
    6.7.2 Adult
    6.8 Market Segmentation By Distribution Channel
    6.8.1 Hospitals And Pharmacies
    6.8.2 Government And Institutional Supply
    6.8.3 Other Distribution Channels
    7 Major Market Trends
    7.1 Technological Advancement To Drive Innovation In The Influenza Vaccine
    7.2 Expansion Of Influenza Vaccine Production Capacity
    7.3 Advancements In Influenza Vaccine Development
    7.4 Strategic Partnerships And Collaborations Among Market Players
    8 Influenza Vaccines Market - Macro Economic Scenario
    8.1 COVID-19 Impact On The Influenza Vaccines Market
    8.2 Impact Of The War In Ukraine On The Influenza Vaccines Market
    8.3 Impact Of High Inflation On The Influenza Vaccines Market
    9 Global Market Size and Growth
    9.1 Market Size
    9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
    9.2.1 Market Drivers 2018 – 2023
    9.2.2 Market Restraints 2018 – 2023
    9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
    9.3.1 Market Drivers 2023 – 2028
    9.3.2 Market Restraints 2023 – 2028
    10 Global Influenza Vaccines Market Segmentation
    10.1 Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.2 Global Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.3 Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.4 Global Influenza Vaccines Market, Segmentation By Age Group, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.5 Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    11 Influenza Vaccines Market, Regional and Country Analysis
    11.1 Global Influenza Vaccines Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    11.2 Global Influenza Vaccines Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12 Asia-Pacific Market
    12.1 Summary
    12.1.1 Market Overview
    12.1.2 Region Information
    12.1.3 Market Information
    12.1.4 Background Information
    12.1.5 Government Initiatives
    12.1.6 Regulations
    12.1.7 Regulatory Bodies
    12.1.8 Major Associations
    12.1.9 Taxes Levied
    12.1.10 Corporate Tax Structure
    12.1.11 Investments
    12.1.12 Major Companies
    12.2 Asia Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.3 Asia Pacific Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.4 Asia Pacific Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.5 Asia-Pacific Influenza Vaccines Market: Country Analysis
    12.6 China Market
    12.7 Summary
    12.7.1 Market Overview
    12.7.2 Country Information
    12.7.3 Market Information
    12.7.4 Background Information
    12.7.5 Government Initiatives
    12.7.6 Regulations
    12.7.7 Regulatory Bodies
    12.7.8 Major Associations
    12.7.9 Taxes Levied
    12.7.10 Corporate Tax Structure
    12.7.11 Investments
    12.7.12 Major Companies
    12.8 China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.9 China Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.10 China Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.11 India Market
    12.12 India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.13 India Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.14 India Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.15 Japan Market
    12.16 Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.17 Japan Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.18 Japan Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.19 Australia Market
    12.20 Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.21 Australia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.22 Australia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.23 Indonesia Market
    12.24 Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.25 Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.26 Indonesia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.27 South Korea Market
    12.28 South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.29 South Korea Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.30 South Korea Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13 Western Europe Market
    13.1 Summary
    13.1.1 Market Overview
    13.1.2 Region Information
    13.1.3 Market Information
    13.1.4 Background Information
    13.1.5 Government Initiatives
    13.1.6 Regulations
    13.1.7 Regulatory Bodies
    13.1.8 Major Associations
    13.1.9 Taxes Levied
    13.1.10 Corporate tax structure
    13.1.11 Investments
    13.1.12 Major Companies
    13.2 Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.3 Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.4 Western Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.5 Western Europe Influenza Vaccines Market: Country Analysis
    13.6 UK Market
    13.7 UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.8 UK Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.9 UK Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.10 Germany Market
    13.11 Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.12 Germany Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.13 Germany Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.14 France Market
    13.15 France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.16 France Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.17 France Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.18 Italy Market
    13.19 Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.20 Italy Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.21 Italy Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.22 Spain Market
    13.23 Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.24 Spain Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.25 Spain Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14 Eastern Europe Market
    14.1 Summary
    14.1.1 Market Overview
    14.1.2 Region Information
    14.1.3 Market Information
    14.1.4 Background Information
    14.1.5 Government Initiatives
    14.1.6 Regulations
    14.1.7 Regulatory Bodies
    14.1.8 Major Associations
    14.1.9 Taxes Levied
    14.1.10 Corporate Tax Structure
    14.1.11 Major companies
    14.2 Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.3 Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.4 Eastern Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.5 Eastern Europe Influenza Vaccines Market: Country Analysis
    14.6 Russia Market
    14.7 Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.8 Russia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.9 Russia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15 North America Market
    15.1 Summary
    15.1.1 Market Overview
    15.1.2 Region Information
    15.1.3 Market Information
    15.1.4 Background Information
    15.1.5 Government Initiatives
    15.1.6 Regulations
    15.1.7 Regulatory Bodies
    15.1.8 Major Associations
    15.1.9 Taxes Levied
    15.1.10 Corporate Tax Structure
    15.1.11 Investments
    15.1.12 Major Companies
    15.2 North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.3 North America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.4 North America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.5 North America Influenza Vaccines Market: Country Analysis
    15.6 USA Market
    15.7 Summary
    15.7.1 Market Overview
    15.7.2 Country Information
    15.7.3 Market Information
    15.7.4 Background Information
    15.7.5 Government Initiatives
    15.7.6 Regulations
    15.7.7 Regulatory Bodies
    15.7.8 Major Associations
    15.7.9 Taxes Levied
    15.7.10 Corporate Tax Structure
    15.7.11 Investments
    15.7.12 Major Companies
    15.8 USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.9 USA Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.10 USA Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.11 Canada Market
    15.12 Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.13 Canada Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.14 Canada Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16 South America Market
    16.1 Summary
    16.1.1 Market Overview
    16.1.2 Region Information
    16.1.3 Market Information
    16.1.4 Background Information
    16.1.5 Government Initiatives
    16.1.6 Regulations
    16.1.7 Regulatory Bodies
    16.1.8 Major Associations
    16.1.9 Taxes Levied
    16.1.10 Corporate Tax Structure
    16.1.11 Investments
    16.1.12 Major Companies
    16.2 South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.3 South America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.4 South America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.5 South America Influenza Vaccines Market: Country Analysis
    16.6 Brazil Market
    16.7 Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.8 Brazil Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.9 Brazil Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17 Middle East Market
    17.1 Summary
    17.1.1 Market Overview
    17.1.2 Region Information
    17.1.3 Market Information
    17.1.4 Background Information
    17.1.5 Government Initiatives
    17.1.6 Regulations
    17.1.7 Regulatory Bodies
    17.1.8 Major Associations
    17.1.9 Taxes Levied
    17.1.10 Corporate Tax Structure
    17.1.11 Major Companies
    17.2 Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17.3 Middle East Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17.4 Middle East Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18 Africa Market
    18.1 Summary
    18.2.1 Market Overview
    18.2.2 Region Information
    18.2.3 Market Information
    18.2.4 Background Information
    18.2.5 Government Initiatives
    18.2.6 Regulations
    18.2.7 Regulatory Bodies
    18.2.8 Major Associations
    18.2.9 Taxes Levied
    18.2.10 Corporate Tax Structure
    18.2.11 Investments
    18.2.12 Major Companies
    18.3 Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18.4 Africa Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18.5 Africa Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    19 Competitive Landscape And Company Profiles
    19.1 Company Profiles
    19.2 Sanofi S.A.
    19.2.1 Company Overview
    19.2.2 Products And Services
    19.2.3 Business Strategy
    19.2.4 Financial Overview
    19.3 Seqirus (CSL Limited)
    19.3.1 Company Overview
    19.3.2 Products And Services
    19.3.3 Business Strategy
    19.3.4 Financial Overview
    19.4 GlaxoSmithKline plc
    19.4.1 Company Overview
    19.4.2 Products And Services
    19.4.3 Business Strategy
    19.4.4 Financial Overview
    19.5 Daiichi Sankyo Co. Ltd
    19.5.1 Company Overview
    19.5.2 Products And Services
    19.5.3 Business Strategy
    19.5.4 Financial Overview
    19.6 Pfizer Inc
    19.6.1 Company Overview
    19.6.2 Products And Services
    19.6.3 Business Strategy
    19.6.4 Financial Overview
    20 Other Major And Innovative Companies
    20.1 Abbott Laboratories
    20.1.1 Company Overview
    20.1.2 Products and Services
    20.2 AstraZeneca Plc
    20.2.1 Company Overview
    20.2.2 Products And Services
    20.3 Sinovac Biotech Ltd
    20.3.1 Company Overview
    20.3.2 Products And Services
    20.4 Serum Institute of India
    20.4.1 Company Overview
    20.4.2 Products And Services
    20.5 BioDiem Ltd
    20.5.1 Company Overview
    20.5.2 Products and Services
    20.6 Takeda Pharmaceutical Company Limited
    20.6.1 Company Overview
    20.6.2 Products and Services
    20.7 EMERGENT BIOSOLUTIONS INC
    20.7.1 Company Overview
    20.7.2 Products and Services
    20.8 BiondVax Pharmaceuticals Ltd
    20.8.1 Company Overview
    20.8.2 Products and Services
    20.9 Gamma Vaccines Pty Ltd
    20.9.1 Company Overview
    20.9.2 Products and Services
    20.10 Osivax
    20.10.1 Company Overview
    20.10.2 Products and Services
    20.11 Vaxart Inc
    20.11.1 Company Overview
    20.11.2 Products and Services
    20.12 Vaxess Technologies Inc
    20.12.1 Company Overview
    20.12.2 Products and Services
    20.13 Biken Techno Corp
    20.13.1 Company Overview
    20.13.2 Products and Services
    20.14 Johnson & Johnson
    20.14.1 Company Overview
    20.14.2 Products and Services
    20.15 Flugen Inc
    20.15.1 Company Overview
    20.15.2 Products and Services
    21 Competitive Benchmarking
    22 Competitive Dashboard
    23 Key Mergers And Acquisitions
    23.1 GSK Acquired CureVac
    23.2 AstraZeneca Acquired Icosavax
    23.3 GSK Acquired Affinivax
    24 Opportunities And Strategies
    24.1 Global Influenza Vaccines Market In 2028 – Countries Offering Most New Opportunities
    24.2 Global Influenza Vaccines Market In 2028 – Segments Offering Most New Opportunities
    24.3 Global Influenza Vaccines Market In 2028 – Growth Strategies
    24.3.1 Market Trend Based Strategies
    24.3.2 Competitor Strategies
    25 Influenza Vaccines Market, Conclusions And Recommendations
    25.1 Conclusions
    25.2 Recommendations
    25.2.1 Product
    25.2.2 Place
    25.2.3 Price
    25.2.4 Promotion
    25.2.5 People
    26 Appendix
    26.1 Geographies Covered
    26.2 Market Data Sources
    26.3 Research Methodology
    26.4 Currencies
    26.5 The Business Research Company
    26.6 Copyright and Disclaimer

    $7,500
    $10,000

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings